SERUM-PROTEINS AND CEREBROSPINAL-FLUID PROTEIN IN TUBERCULOUS MENINGITIS

The Lancet ◽  
1957 ◽  
Vol 270 (7008) ◽  
pp. 1288
Author(s):  
Z ERDOS
PLoS ONE ◽  
2021 ◽  
Vol 16 (4) ◽  
pp. e0250944
Author(s):  
Charles M. Manyelo ◽  
Novel N. Chegou ◽  
James A. Seddon ◽  
Candice I. Snyders ◽  
Hygon Mutavhatsindi ◽  
...  

Introduction Stroke is a common complication in children with tuberculous meningitis (TBM). Host proteins may give us insight into the mechanisms of stroke in TBM and serve as biomarkers for detection of stroke, however, they have not been widely explored. In this study, we compared the concentrations of cerebrospinal fluid (CSF) and serum proteins between children who had TBM-related stroke and children with TBM without stroke. Methods We collected CSF and serum from 47 children consecutively admitted to the Tygerberg Academic Hospital in Cape Town, South Africa between November 2016, and November 2017, on suspicion of having TBM. A multiplex platform was used to measure the concentrations of 69 host proteins in CSF and serum from all study participants. Results After classification of study participants, 23 (48.9%) out of the 47 study participants were diagnosed with TBM, of which 14 (60.9%) demonstrated radiological arterial ischemic infarction. The levels of lipocalin-2, sRAGE, IP-10/ CXCL10, sVCAM-1, MMP-1, and PDGF-AA in CSF samples and the levels of D-dimer, ADAMTS13, SAA, ferritin, MCP-1/ CCL2, GDF-15 and IL-13 in serum samples were statistically different between children who had TBM-related stroke and children with TBM without stroke. After correcting for multiple testing, only the levels of sVCAM-1, MMP-1, sRAGE, and IP-10/ CXCL10 in CSF were statistically different between the two groups. CSF and serum protein biosignatures indicated stroke in children diagnosed with TBM with up to 100% sensitivity and 88.9% specificity. Conclusion Serum and CSF proteins may serve as biomarkers for identifying individuals with stroke amongst children diagnosed with TBM at admission and may guide us to understand the biology of stroke in TBM. This was a pilot study, and thus further investigations in larger studies are needed.


2019 ◽  
Vol 23 (6) ◽  
pp. 765-765
Author(s):  
A. Figaji ◽  
G. Fieggen ◽  
N. Enslin ◽  
A. Taylor ◽  
U. Rohlwink

1987 ◽  
Vol 47 (8) ◽  
pp. 765-769
Author(s):  
R. Marra ◽  
L. Pagano ◽  
S. Storti ◽  
A. Massaro ◽  
L. Teofili ◽  
...  

Author(s):  
Arti Maria ◽  
Tapas Bandyopadhyay

AbstractWe describe the case of a term newborn who presented with hypernatremic dehydration on day 19 of life. The baby was otherwise hemodynamically stable with no evidence of focal or asymmetric neurological signs. The laboratory tests at the time of admission were negative except for hypernatremia and the extremely elevated levels of cerebrospinal fluid (CSF) protein (717 mg/dL) and glucose levels (97 mg/dL). The hypernatremic dehydration was corrected as per the unit protocol over 48 hours. Repeat CSF analysis done after 5 days showed normalization of the protein and glucose levels. Serial follow-up and neuroimaging showed no evidence of neurological sequelae. Unique feature of our case is this is the first case reporting such an extreme elevation of CSF protein and glucose levels that have had no bearing on neurodevelopmental outcome at 1 month and 3 months of follow-up.


Author(s):  
Annapurna Rai ◽  
Rajniti Prasad ◽  
B.K. Das ◽  
Shampa Anupurba ◽  
Utpal Kant Singh

Sign in / Sign up

Export Citation Format

Share Document